Profil
Jeffrey Barnes, MS, MBA, joined BioVentures Investors in 2010 and is currently a Managing Director.
He brings over 35 years of start-up, operating, and investment experience in the life sciences and healthcare sectors.
Prior to joining BioVentures Investors, Jeff was Managing Partner at Oxford Bioscience Partners, a venture fund.
There, he was responsible for building and leading the firm's investment strategy in medical devices and diagnostic instrumentation, as well as originating and overseeing investments in 18 portfolio companies.
Jeff was instrumental in the successful acquisition of seven medical device companies by strategic acquirers, including Edwards Lifesciences, Medtronic, ThermoFisher, Boston Scientific and Olympus Corp.
Prior to venture capital, Jeff spent eight years in investment banking within the healthcare groups of Needham & Co. and Robertson, Stephens & Co.
Previously, Jeff had over 12 years of operating experience in the medical products field, including eight years in management positions in research and development, manufacturing, and marketing within the Medical Products Group of Hewlett-Packard Corp.
He has served on the Board of Directors of more than 20 public and private healthcare technology companies, and he holds patents in diagnostic imaging technology and physiological signal processing.
In addition, Jeff has been a co-founder of numerous medical device start-ups, including Mitralign, Circulite, Accelerated Technologies, Percutaneous Valve Technologies, Applied Spine Technologies, and Claros Diagnostics.
Jeff holds a BS degree in Physiology and Biophysics and an MS degree in Biomedical Engineering from Duke University, and an MBA degree in Management from Stanford University.
Postes actifs de Jeffrey T. Barnes
| Sociétés | Poste | Début |
|---|---|---|
X-Cell Medical, Inc.
X-Cell Medical, Inc. Medical SpecialtiesHealth Technology Develops drugs for cardiovascular clinical applications | Directeur/Membre du Conseil | 11/04/2011 |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Private Equity Investor | 01/01/2010 |
CoNextions Medical Corp.
CoNextions Medical Corp. Medical SpecialtiesHealth Technology Provides tendon repairs solutions | Président | - |
Anciens postes connus de Jeffrey T. Barnes
| Sociétés | Poste | Fin |
|---|---|---|
| PROSPECT PARK CAPITAL CORP. | Directeur/Membre du Conseil | 23/01/2020 |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Private Equity Investor | 30/07/2009 |
Criticare Systems, Inc.
Criticare Systems, Inc. Medical SpecialtiesHealth Technology Provides medical equipment and supplies | Directeur/Membre du Conseil | - |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Corporate Officer/Principal | 01/10/1999 |
Cambridge Endoscopic Devices, Inc.
Cambridge Endoscopic Devices, Inc. Medical SpecialtiesHealth Technology Manufactures surgical and medical devices | Directeur/Membre du Conseil | - |
Formation de Jeffrey T. Barnes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Criticare Systems, Inc.
Criticare Systems, Inc. Medical SpecialtiesHealth Technology Provides medical equipment and supplies | Health Technology |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investments provides investment advice to separately managed accounts and pooled investment vehicles across a range of investment strategies and styles. The firm offers value strategies, growth strategies, emerging markets, and international developed markets. In addition, they oversee the management of various fixed income strategies and a natural resources strategy (offered through the RS mutual funds). Sub-advisers manage the day-to-day investment programs of these strategies. | Finance |
IntraPace, Inc.
IntraPace, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops implantable gastric pacemaker for treatment of obesity | Health Technology |
HydroCision, Inc.
HydroCision, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets fluid-jet based surgical tools | Health Technology |
Mitralign, Inc.
Mitralign, Inc. Medical SpecialtiesHealth Technology Engages in the development of medical devices | Health Technology |
FlowMedica, Inc.
FlowMedica, Inc. Medical SpecialtiesHealth Technology Develops intravascular systems and medical devices | Health Technology |
Cambridge Endoscopic Devices, Inc.
Cambridge Endoscopic Devices, Inc. Medical SpecialtiesHealth Technology Manufactures surgical and medical devices | Health Technology |
Prospect Park Capital Corp.
Prospect Park Capital Corp. Financial ConglomeratesFinance Provides investment services | Finance |
CoNextions Medical Corp.
CoNextions Medical Corp. Medical SpecialtiesHealth Technology Provides tendon repairs solutions | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Health Technology |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Finance |
X-Cell Medical, Inc.
X-Cell Medical, Inc. Medical SpecialtiesHealth Technology Develops drugs for cardiovascular clinical applications | Health Technology |
OPKO Diagnostics LLC
OPKO Diagnostics LLC Medical/Nursing ServicesHealth Services Provides health services | Health Services |
















